BiomX Inc. — Director's Dealing 2021

Jul 30, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BiomX Inc. (PHGE)
CIK: 0001739174
Period of Report: 2021-07-28

Reporting Person: Greig Russell (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-28	Common Stock	P	3750	$4.00	Acquired	3750	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-28	Common Stock Warrant	$5.00	P	2813	Acquired	2027-01-28	Common Stock (2813)	Indirect

Footnotes

F1: The common stock and common stock warrant were acquired in the issuer's registered direct offering of units, in which each unit consisted of one share of common stock and one common stock warrant to purchase 0.75 of a share of common stock, at a price of $4.00 per unit. The price paid per unit is reflected in Table I.

F2: The common stock warrant will be exercisable six months after the date of issuance, at an exercise price of $5.00 per share and will expire five years from the date such warrant first becomes exercisable.

F3: The common stock and common stock warrant are held by Greig Biotechnology Global Consulting Inc.; Mr. Greig, as the sole director, an officer and the controlling shareholder of Greig Biotechnology Global Consulting Inc., may be deemed to be a beneficial owner of these shares, but Mr. Greig disclaims such beneficial ownership except to the extent of his pecuniary interest therein.